Inter-Rater Reliability of the CASCADE Criteria: Challenges in Classifying Arteriopathies.

Stroke

From the Section of Child Neurology (T.J.B., J.A.-W., R.B.), Section of Hematology/Oncology/BMT (M.J.M.-J.), Hemophilia and Thrombosis Center, Department of Pediatrics (T.J.B., M.J.M.-J., J.A.-W., A.H.), Department of Pediatrics (T.J.B, M.J.M-J, J.A-W., R.B.), Department of Biostatistics and Informa

Published: October 2016


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background And Purpose: There are limited data about the reliability of subtype classification in childhood arterial ischemic stroke, an issue that prompted the IPSS (International Pediatric Stroke Study) to develop the CASCADE criteria (Childhood AIS Standardized Classification and Diagnostic Evaluation). Our purpose was to determine the CASCADE criteria's reliability in a population of children with stroke.

Methods: Eight raters from the IPSS reviewed neuroimaging and clinical records of 64 cases (16 cases each) randomly selected from a prospectively collected cohort of 113 children with arterial ischemic stroke and classified them using the CASCADE criteria. Clinical data abstracted included history of present illness, risk factors, and acute imaging. Agreement among raters was measured by unweighted κ statistic.

Results: The CASCADE criteria demonstrated a moderate inter-rater reliability, with an overall κ statistic of 0.53 (95% confidence interval [CI]=0.39-0.67). Cardioembolic and bilateral cerebral arteriopathy subtypes had much higher agreement (κ=0.84; 95% CI=0.70-0.99; and κ=0.90; 95% CI=0.71-1.00, respectively) than cases of aortic/cervical arteriopathy (κ=0.36; 95% CI=0.01-0.71), unilateral focal cerebral arteriopathy of childhood (FCA; κ=0.49; 95% CI=0.23-0.76), and small vessel arteriopathy of childhood (κ=-0.012; 95% CI=-0.04 to 0.01).

Conclusions: The CASCADE criteria have moderate reliability when used by trained and experienced raters, which suggests that it can be used for classification in multicenter pediatric stroke studies. However, the moderate reliability of the arteriopathic subtypes suggests that further refinement is needed for defining subtypes. Such revisions may reduce the variability in the literature describing risk factors, recurrence, and outcomes associated with childhood arteriopathy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764077PMC
http://dx.doi.org/10.1161/STROKEAHA.116.013544DOI Listing

Publication Analysis

Top Keywords

cascade criteria
20
inter-rater reliability
8
arterial ischemic
8
ischemic stroke
8
pediatric stroke
8
risk factors
8
cerebral arteriopathy
8
arteriopathy childhood
8
moderate reliability
8
cascade
6

Similar Publications

Touch facilitates newborns' self-regulation: Systematic review of multidimensional arousal outcomes.

Neurosci Biobehav Rev

September 2025

Chair of Acoustics and Haptics, Centre for Tactile Internet with Human-in-the-Loop (CeTI), Technische Universität Dresden, Germany.

During the first month of life, exchanges between newborns and caregivers focus on helping babies regulate their physiological and behavioural states. Touch and bodily contact play a special role in facilitating arousal regulation and are often used to promote bonding, support at-risk babies, and manage pain. Here, we systematically review the extant evidence on the effects of touch interventions for newborns, specifically focusing on self-regulation and arousal as outcome measures.

View Article and Find Full Text PDF

This study aimed to develop and validate a Multidimensional Impact of Cancer Risk Assessment questionnaire-Japanese version (MICRA-J) as an assessment of the psychosocial impact of genetic testing. The MICRA was translated into Japanese using standardized translation procedures. The reliability and validity of the MICRA-J were evaluated in individuals who underwent BRCA1/2 testing for hereditary breast and ovarian cancer diagnosis.

View Article and Find Full Text PDF

Background And Objective: Hemadsorption, a therapeutic modality traditionally used to mitigate cytokine storm in critically ill patients and is now being tested in other medical fields including organ transplantation, especially for organs from extended criteria donors. Such organs are susceptible to ischemia-reperfusion injury (IRI) during transplantation, which is known to release a cascade of innate immune mediators including damage-associated molecular patterns (DAMPs) and cytokines during reperfusion and ultimately leading to graft dysfunction based on the metabolic injury. To address this challenge, early studies have integrated hemadsorption filters into organ perfusion circuits, such as normothermic regional perfusion (NRP) in donors and machine perfusion (MP) of grafts, with the aim to reduce inflammation and improve organ viability.

View Article and Find Full Text PDF

Long-term impact of national tuberculosis program interventions on incidence and disparities by age and geography.

BMC Infect Dis

September 2025

Changhua Public Health Bureau, No.162, Sec. 2, Jhongshan Rd., Changhua City, Changhua County 500, Taiwan.

Background: Evaluations of the national tuberculosis control programs (NTPs) frequently lacked insights into the uneven long-term impacts on distinct age groups and geographic regions.

Methods: We analyzed tuberculosis cases notified from 1990 to 2019 in Changhua, Taiwan. A Bayesian hierarchical change-point model was developed to estimate the NTP’s effects on different age groups and townships and project the long-term tuberculosis incidence trend to 2035.

View Article and Find Full Text PDF

Background: Psoriasis is a chronic immune-mediated skin disease that significantly impacts patients' quality of life due to its physical, psychological, and systemic burden. Phosphodiesterase-4 (PDE-4) plays a pivotal role in the inflammatory cascade of the disease through the modulation of intracellular cyclic adenosine monophosphate (cAMP) levels. This systematic review evaluates current evidence on the clinical efficacy and safety of novel PDE-4 inhibitors in the treatment of psoriasis.

View Article and Find Full Text PDF